Viewing StudyNCT00147498



Ignite Creation Date: 2024-05-05 @ 11:49 AM
Last Modification Date: 2024-10-26 @ 9:14 AM
Study NCT ID: NCT00147498
Status: COMPLETED
Last Update Posted: 2013-01-30
First Post: 2005-09-02

Brief Title: Three Dose Levels of CP-690550 Monotherapy Versus Placebo Administered Orally Twice Daily BID for 6 Weeks
Sponsor: Pfizer
Organization: Pfizer

Conditions & Keywords Data

Conditions:
Name
Rheumatoid Arthritis
Keywords:
Name View
Immune System Diseases View
oral JAK inhibitor View
clinical trial View
joint diseases View
anti-Inflammatory agents View
rheumatic diseases View
DMARD View
Antirheumatic Agents View
Autoimmune Diseases View